WPRIM Management System> DCMS> Journal of International Oncology> 2012> 39> 5

Volume: 39 Issue: 5

1. Autophagy and cancer Page:323—326
2. Mechanisms of oxaliplatin neurotoxicity and its predictions Page:366—369
3. Anti-tumor clinical research of mTOR inhibitor Page:363—366
4. Cytokine-induced killer cells in cancer treatment Page:344—347
5. Expression of COX-2 and survivin protein in elderly patients with gastric cancer and its metastasis and prognosis Page:387—390
6. Hepatocyte growth factor and its receptor in multiple myeloma Page:384—386
7. Epithelial-mesenchymal transition in digestive system tumors Page:380—383
8. Drug resistance related factors and cancer metastasis Page:359—362
9. Astrocyte elevated gene 1 in malignant tumor Page:341—344
10. Regulation of cyclin E and cancers Page:337—340
11. Advances of miR-221/222 in tumors Page:330—333
12. Basal-like breast cancer Page:377—380
13. Treatment of recurrent small cell lung cancer Page:373—376
14. Cyclin D1 G870A polymorphism and the risk of colorectal cancer: a systematic review Page:395—400
15. Dosimetric difference in RapidArc planning for radiotherapy of multiple hepatic malignancy using different photon energy Page:391—395
16. Exhaled volatile organic compounds detection in cancer diagnosis Page:370—373
17. Mechanism and treatment associated with resistance to EGFR-TKI Page:355—359
18. Angiopoietin-2 and tumor angiogenesis Page:352—355
19. Anti-tumor mechanism of CIK cells and research Page:348—351
20. MicroRNA and cancer Page:333—337
21. Neoplasms-associated autophagy signaling pathways Page:326—329